Randomized controlled trial of induction therapy for thoracic esophageal cancer invading aorta or trahcea

Randomized controlled trial of induction therapy for thoracic esophageal cancer invading aorta or trahcea - Randomized controlled trial of induction therapy for thoracic esophageal cancer invading aorta or trahcea

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014718

Enrollment

160

Registered

2014-07-31

Start date

2014-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thoracic esophageal cancer

Interventions

induction therapy is chemotharpy induction therapy is chemoadiotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Thoracic esophageal squamous cell carcinoma invaindg aorta or trachea

Exclusion criteria

Exclusion criteria: Cases with metastatic lymph nodes in abdominal lesions

Design outcomes

Primary

Measure	Time frame
overall survival	—

Countries

Japan

Contacts

Public ContactKeijiro Sugimura

Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Digestive Surgery

sugimura-ke@mc.pref.osaka.jp06-6972-1181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026